Last update:
Weight management news
Researchers identify avenue for enhanced GLP-1-induced weight loss
A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor agonists trigger within neurons, which have been largely unexplored until now. A study in mice identified ...
6 hours ago
0
3
What you eat as a teenager may shape food choices later in life
New research from the University of Aberdeen Rowett Institute suggests that an unhealthy diet during adolescence could have long-lasting effects on how the brain makes decisions about food—even after returning to a healthy ...
23 hours ago
0
3
UK's younger generations likelier to experience poor health earlier in life than previous cohorts, research shows
Younger generations appear to be experiencing poorer health earlier in life than previous generations, according to a review of studies comparing national birth cohort datasets involving tens of thousands of people across ...
16 hours ago
0
3
As GLP-1 drugs surge in popularity, bariatric surgery rates plunge across the US
For a very long time, bariatric surgery, in which doctors removed a portion of the stomach, was the standard procedure for helping patients lose weight and manage obesity, alongside metabolic disorders such as diabetes, high ...
AI atlas reveals hidden whole-body-damage caused by obesity
Obesity affects far more than metabolism and fat storage. It alters immune activity, nerve structure, and tissue organization across multiple organ systems, increasing the risk of diseases including type 2 diabetes, cardiovascular ...
May 20, 2026
0
60
Quitting smoking associated with lower dementia risk, but weight gain may reduce the benefit
Quitting smoking may be associated with a lowered risk of dementia, especially for people who avoid major weight gain after quitting, according to a study published in Neurology. The study does not prove that quitting smoking ...
May 20, 2026
0
3
BMI alone does not fully capture health risks linked to obesity, new study finds
Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and AstraZeneca show that integrating measurements such as body fat percentage and waist circumference captures ...
May 19, 2026
1
8
Over half of type 2 diabetes cases could be preventable, study shows
A new study led by researchers at the University of Massachusetts Amherst suggests that even people with a high genetic risk for type 2 diabetes can substantially reduce their chances of developing the disease by adopting ...
May 19, 2026
0
10
Lipedema: The painful condition too often dismissed as obesity
For many women with lipedema, the diagnosis comes after years of being told the same thing: eat less, not more. The problem is that the fat accumulating around their hips and legs isn't responding to diet or exercise, because ...
May 19, 2026
0
3
Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid
Biomedical engineers at Duke University have developed a new approach to delivering GLP-1 medications orally that does not require fasting and maintains their efficacy. The technique could also be useful for any pharmaceutical ...
May 19, 2026
0
4
Text messages aid in reducing cardiovascular risk in adults with psoriasis
A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis, according to a study published online May 13 in JAMA Dermatology.
May 19, 2026
0
3
Which patients benefit most from tirzepatide GLP-1 for obesity and obstructive sleep apnea?
Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, but not all patients benefit equally. Now, new research presented at the 2026 ATS International ...
May 19, 2026
0
7
At 'most favored nation' prices, can Medicare break even on GLP-1 drugs?
In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...
May 18, 2026
0
7
Wealth and health divide: Obesity rates plateau in rich nations but surge in developing world
Obesity has long been the invisible health crisis looming over humanity, with rates climbing globally. There is some positive news now emerging from a multi-decade study spanning several nations. A recent study published ...
Weight-loss drugs tied to lower death, recurrence risk after breast cancer
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
May 17, 2026
0
22
Does an infant's body fat relate to cognitive and motor development?
As every parent knows, an infant's early life is a series of milestones, from logging every development to regular checkups with the pediatrician to monitor body length, head circumference, and weight.
May 17, 2026
0
6
Stronger regulation needed to address injectable peptide craze
Tougher regulation on peptide supplies is needed as illegal use skyrockets among young Australians, University of Queensland researchers say. Dr. Timothy Piatkowski, of UQ's School of Public Health, said the country's regulatory ...
May 16, 2026
0
13
Muscle mass is preserved after obesity drug treatment, study suggests
New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass ...
May 16, 2026
0
12
Is 'yo‑yo dieting' really harmful? New analysis challenges longstanding assumptions about weight cycling
Weight loss followed by weight regain, commonly known as "yo-yo dieting" or weight cycling, is often portrayed as harmful, even more damaging than remaining overweight. But a new comprehensive analysis published in The Lancet ...
May 15, 2026
0
15
Trial shows rapid weight loss is much more effective than gradual weight loss, challenging prevailing beliefs
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) is much more effective than gradual weight loss (GWL) in both achieving higher weight loss and ...
May 15, 2026
0
9
New obesity guidance urges dietitian-led care as GLP-1 drugs reshape treatment
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The consensus statement was presented at the European ...
May 15, 2026
0
7
Analysis shows how using obesity drugs for weight loss is associated with a clinically relevant drop in blood pressure
A meta-analysis of 32 studies and 43,618 adults presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows that use of new classes of obesity drugs for weight loss is associated with a clinically ...
May 15, 2026
0
6
Wegovy initiation may cut migraine drug use 8% in women after one year
A nationwide study from Denmark presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use of semaglutide (Wegovy) for weight management is associated with a 7% reduction in the use of triptan-class ...
May 15, 2026
0
5
Study links use of new obesity drugs to reduction of asthma exacerbations and inhaler use
New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26% fall in the number of asthma ...
May 15, 2026
0
5
How understanding art history can help doctors treat obesity
Understanding how obesity has been portrayed in art across the ages can make doctors more empathetic and less judgmental, which should lead to their patients achieving better outcomes, new research at the European Congress ...
May 14, 2026
0
5
